DD223444A5 - Verfahren zur herstellung von 5-acyl-2-(1h)-pyridinonen - Google Patents

Verfahren zur herstellung von 5-acyl-2-(1h)-pyridinonen Download PDF

Info

Publication number
DD223444A5
DD223444A5 DD84262415A DD26241584A DD223444A5 DD 223444 A5 DD223444 A5 DD 223444A5 DD 84262415 A DD84262415 A DD 84262415A DD 26241584 A DD26241584 A DD 26241584A DD 223444 A5 DD223444 A5 DD 223444A5
Authority
DD
German Democratic Republic
Prior art keywords
dimethylamino
methylenyl
compounds
propanedione
mol
Prior art date
Application number
DD84262415A
Other languages
German (de)
English (en)
Inventor
Winton D Jones
Richard A Schnettler
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DD223444A5 publication Critical patent/DD223444A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD84262415A 1983-04-29 1984-04-27 Verfahren zur herstellung von 5-acyl-2-(1h)-pyridinonen DD223444A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/490,081 US4568751A (en) 1983-04-29 1983-04-29 5-Acyl-2-(1H)-pyridinones

Publications (1)

Publication Number Publication Date
DD223444A5 true DD223444A5 (de) 1985-06-12

Family

ID=23946554

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84262415A DD223444A5 (de) 1983-04-29 1984-04-27 Verfahren zur herstellung von 5-acyl-2-(1h)-pyridinonen

Country Status (22)

Country Link
US (1) US4568751A (da)
EP (2) EP0124089B1 (da)
JP (2) JPS59206355A (da)
KR (2) KR900005011B1 (da)
AR (1) AR240313A1 (da)
AT (2) ATE26262T1 (da)
AU (2) AU571219B2 (da)
CA (2) CA1256880A (da)
DD (1) DD223444A5 (da)
DE (2) DE3462503D1 (da)
DK (2) DK159425C (da)
ES (2) ES8505955A1 (da)
GR (2) GR81967B (da)
HU (2) HU191753B (da)
IE (2) IE57285B1 (da)
IL (2) IL71649A (da)
NO (2) NO164415C (da)
NZ (2) NZ207961A (da)
PH (1) PH20256A (da)
PT (2) PT78491B (da)
SU (1) SU1299505A3 (da)
ZA (2) ZA843034B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731371A (en) * 1984-03-29 1988-03-15 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles which are useful as cardiotonic agents
US4853395A (en) * 1983-04-29 1989-08-01 Merrell Dow Pharmaceuticals Inc. Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties
US5428045A (en) * 1983-04-29 1995-06-27 Merrell Dow Pharmaceuticals Inc. 5-acyl-2-(1H)-pyridinoes
US5118696A (en) * 1983-04-29 1992-06-02 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure
US4992452A (en) * 1983-04-29 1991-02-12 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4732982A (en) * 1983-11-03 1988-03-22 Merrell Dow Pharmaceuticals Inc. Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4657919A (en) * 1984-08-03 1987-04-14 E. I. Du Pont De Nemours & Co. Pyridone esters as inotropic agents
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531035A1 (de) * 1975-07-11 1977-01-27 Basf Ag Verfahren zur herstellung von 5-cyanpyridonen-(6)
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
GB1596887A (en) * 1977-07-15 1981-09-03 Rohm & Haas 2-pyridone derivatives and their use as plant growth regulators
DE3005069A1 (de) * 1980-02-11 1981-08-20 Cassella Ag, 6000 Frankfurt Pyridonderivate, ihre herstellung und ihre verwendung
DE3106460A1 (de) * 1980-03-03 1982-01-28 Sandoz-Patent-GmbH, 7850 Lörrach 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
US4412077A (en) * 1982-03-15 1983-10-25 Sterling Drug Inc. Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
US4524149A (en) * 1982-03-15 1985-06-18 Sterling Drug Inc. 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
GR81990B (da) 1984-12-12
DE3462889D1 (de) 1987-05-07
EP0124090A1 (en) 1984-11-07
AR240313A1 (es) 1990-03-30
HUT34006A (en) 1985-01-28
DK159424C (da) 1991-03-18
NZ207960A (en) 1987-05-29
JPS59206356A (ja) 1984-11-22
ZA843034B (en) 1984-11-28
AU571219B2 (en) 1988-04-14
ES531910A0 (es) 1985-06-01
GR81967B (da) 1984-12-12
IL71648A0 (en) 1984-07-31
NO164415B (no) 1990-06-25
IE841047L (en) 1984-10-29
JPH0579668B2 (da) 1993-11-04
KR840008322A (ko) 1984-12-14
ES531911A0 (es) 1985-06-01
AU557543B2 (en) 1986-12-24
SU1299505A3 (ru) 1987-03-23
IL71648A (en) 1987-11-30
AU2714184A (en) 1984-11-01
ATE25678T1 (de) 1987-03-15
NO841691L (no) 1984-10-30
DK159425C (da) 1991-03-18
CA1256880A (en) 1989-07-04
NZ207961A (en) 1986-09-10
EP0124089B1 (en) 1987-03-04
AU2713184A (en) 1984-11-01
NO164416C (no) 1990-10-03
ES8505955A1 (es) 1985-06-01
HU191753B (en) 1987-04-28
HU191928B (en) 1987-04-28
DK213284A (da) 1984-10-30
PH20256A (en) 1986-11-14
IL71649A (en) 1987-10-30
US4568751A (en) 1986-02-04
DK213584A (da) 1984-10-30
DK159425B (da) 1990-10-15
NO164416B (no) 1990-06-25
PT78491A (en) 1984-05-01
PT78493B (en) 1986-05-20
KR840008323A (ko) 1984-12-14
IE57285B1 (en) 1992-07-15
PT78493A (en) 1984-05-01
ES8505956A1 (es) 1985-06-01
ATE26262T1 (de) 1987-04-15
JPH058192B2 (da) 1993-02-01
NO841690L (no) 1984-10-30
PT78491B (en) 1986-05-22
DE3462503D1 (en) 1987-04-09
ZA843033B (en) 1984-11-28
NO164415C (no) 1990-10-03
KR900005010B1 (ko) 1990-07-16
CA1242443A (en) 1988-09-27
HUT34007A (en) 1985-01-28
EP0124090B1 (en) 1987-04-01
DK213284D0 (da) 1984-04-27
IE841046L (en) 1984-10-29
DK159424B (da) 1990-10-15
JPS59206355A (ja) 1984-11-22
KR900005011B1 (ko) 1990-07-16
EP0124089A1 (en) 1984-11-07
IL71649A0 (en) 1984-07-31
IE57273B1 (en) 1992-07-01
DK213584D0 (da) 1984-04-27

Similar Documents

Publication Publication Date Title
DE2658544C2 (de) Carbostyrilderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2458965B2 (de) 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2706977A1 (de) Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
EP0276803B1 (de) 1-(4-Hydroxy-3,5-di-tert.-butyl-benzoyl)-homopiperazin, verschiedene von dessen Derivaten, Verfahren zur Herstellung dieser Verbindungen, die sie enthaltenden Arzneimittel und ihre Verwendung
DE2734678A1 (de) Epininester und verfahren zu ihrer herstellung
DD223444A5 (de) Verfahren zur herstellung von 5-acyl-2-(1h)-pyridinonen
EP0538783B1 (de) N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft
EP0104423B1 (de) 2-Nitro-1,1-ethendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0316279A2 (de) Veresterte azacyclische Hydroxyverbindungen
DE2253750C3 (de) Apovincaminsaure-alkylester, Verfahren zu ihrer Herstellung und pharmazeutische
DE2512609A1 (de) Pharmazeutische zubereitung
DE2446100C3 (de) Phenoxyalkancarbonsäureamide von Thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel
DE2941592A1 (de) 2,6-diaminonebularine und verfahren zu deren herstellung
DE1967080C3 (de) t-(3,4-Methylendioxybeiizoyl)-2methyl-5-methoxy-3-indolylessigsäureester, Verfahren zu ihrer Herstellung und Arzneipräparate
DE3023206A1 (de) Indometacin-ester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3021169A1 (de) Pivaloyloxymethyl-2-propylpentanoat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE2739380A1 (de) N-substituierte 2-hydrazono-propionsaeure-derivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten
DE2535599A1 (de) Substituierte zimtsaeureamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende zubereitungen
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
EP0088323B1 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2526795A1 (de) Sulfonamide
DE2235406C3 (de) 2-Amino-4H-pyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2253554C3 (de) 2-Amino-2-oxazoline, Verfahren zu ihrer Herstellung und deren Verwendung zur Erhöhung des Blutdrucks
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE2942065A1 (de) Neue 1,6-naphthyridinderivate, verfahren zu ihrer herstellung sowie mittel gegen schwindel und zur verbesserung der zerebralen zirkulation, die diese derivate enthalten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee